Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.33 |
| ▸ | USP2 | O75604 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | RECQL | P46063 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28127347 | 0.84 | ALDH1A1 (0.35) | TSHRLMNAALDH1A1HPGD | |
| SCHEMBL18537807 | 0.80 | SMN1; SMN2 (0.38) | TSHRSMN1; SMN2ALDH1A1 | |
| SCHEMBL18539505 | 0.75 | — | — | |
| SCHEMBL18537810 | 0.74 | ALDH1A1 (0.49) | LMNAALDH1A1 | |
| SCHEMBL16674847 | 0.74 | SLC7A5 (0.36) | — | |
| SCHEMBL16670214 | 0.74 | SLC7A5 (0.36) | — | |
| SCHEMBL16670213 | 0.74 | SLC7A5 (0.36) | — | |
| SCHEMBL18523374 | 0.70 | USP2 (0.40) | TSHRSMN1; SMN2USP2LMNACYP3A4 | |
| SCHEMBL18523375 | 0.70 | USP2 (0.40) | TSHRSMN1; SMN2USP2LMNACYP3A4 | |
| SCHEMBL18523389 | 0.70 | USP2 (0.40) | TSHRSMN1; SMN2USP2LMNACYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-106467464-B | (E) -2-isopropyl-5-methyl-3, 5-hexadienoic acid ester compound and production method and application thereof | 信越化学工业株式会社 | 2020-12-29 | — | — | CN | disclosed |
| US-9725400-B2 | (E)-2-isopropyl-5-methyl-3,5-hexadienoate compound, method for producing the same, and methods for producing (E)-2-isopropyl-5-methyl-3,5-hexadienol and (E)-2-isopropyl-5-methyl-3,5-hexadienyl carboxylate by using the same | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2017-08-08 | — | — | US | disclosed |
| US-9725400-B2 | (E)-2-isopropyl-5-methyl-3,5-hexadienoate compound, method for producing the same, and methods for producing (E)-2-isopropyl-5-methyl-3,5-hexadienol and (E)-2-isopropyl-5-methyl-3,5-hexadienyl carboxylate by using the same | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2017-08-08 | — | — | US | disclosed |
| CN-106467464-A | (E) 2 isopropyl 5 methyl 3,5 hexadienoic acid ester compounds and its production method and produce (E) 2 isopropyl 5 methyl 3 using it, 5 hexadienols and the method for (E) 2 isopropyl 5 methyl 3,5 hexadienyl carboxylate | 信越化学工业株式会社 | 2017-03-01 | — | — | CN | disclosed |
| US-20170050913-A1 | (E)-2-ISOPROPYL-5-METHYL-3,5-HEXADIENOATE COMPOUND, METHOD FOR PRODUCING THE SAME, AND METHODS FOR PRODUCING (E)-2-ISOPROPYL-5-METHYL-3,5-HEXADIENOL AND (E)-2-ISOPROPYL-5-METHYL-3,5-HEXADIENYL CARBOXYLATE BY USING THE SAME | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2017-02-23 | — | — | US | disclosed |
| US-20170050913-A1 | (E)-2-ISOPROPYL-5-METHYL-3,5-HEXADIENOATE COMPOUND, METHOD FOR PRODUCING THE SAME, AND METHODS FOR PRODUCING (E)-2-ISOPROPYL-5-METHYL-3,5-HEXADIENOL AND (E)-2-ISOPROPYL-5-METHYL-3,5-HEXADIENYL CARBOXYLATE BY USING THE SAME | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2017-02-23 | — | — | US | disclosed |
| EP-3133053-A1 | (E)-ISOPROPYL-5-METHYL-3,5-HEXADIENOATE COMPOUND, METHOD FOR PRODUCING THE SAME, AND METHODS FOR PRODUCING (E)-2-ISOPROPYL-5-METHYL-3,5-HEXADIENOL AND (E)-2-ISOPROPYL-5-METHYL-3,5-HEXADIENYL CARBOXYLATE BY USING THE SAME | Shin-Etsu Chemical Co., Ltd. (JP) | 2017-02-22 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170050913-A1 | (E)-2-ISOPROPYL-5-METHYL-3,5-HEXADIENOATE COMPOUND, METHOD FOR PRODUCING THE SAME, AND METHODS FOR PRODUCING (E)-2-ISOPROPYL-5-METHYL-3,5-HEXADIENOL AND (E)-2-ISOPROPYL-5-METHYL-3,5-HEXADIENYL CARBOXYLATE BY USING THE SAME | SHBG, GNE, PGRMC2 | TSHR 4112/4885SMN1; SMN2 3564/4885USP2 2765/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.